1. Modifications in Mutational Landscape in Patients with Lower Risk MDS without 5Q Deletion Receiving Azacitidine Are Correlated with Clinical Response. (April 2017) Authors: Sanchez-Garcia, J.; Hernandez-Sanchez, J.M.; Falantes, J.; Benito, R.; Medina, A.; Lumbreras, E.; Hernandez-Mohedo, F.; Hermosin, L.; Bailen, A.; Maria, S.; Casaño, J.; Calderon, C.; Labrador-Mateo, M.; Serrano, J.; Hernandez-Rivas, J.M. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-063: Awareness of venous thromboembolism in patients with cancer: does the gender matter?. Issue 151 (March 2017) Authors: Nicolau, B.; García-Morilla, M.; Stefi Cortes, K.; Calderon, C.; Gascon, P.; Suarez, C.; Jara Palomares, L.; Colomé, E.; Manazaneda, J.; Fernandez-Ortega, P.; Otero, R.; Monreal, M.; Font, C. Journal: Thrombosis research Issue: Issue 151(2017)Supplement 1 Page Start: S129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The pore forming capacity of Sticholysin I in dipalmitoyl phosphatidyl vesicles is tuned by osmotic stress. (March 2017) Authors: Ahumada, M.; Calderon, C.; Lissi, E.; Alvarez, C.; Lanio, M.E.; Pazos, F. Journal: Chemistry and physics of lipids Issue: Volume 203(2017) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗